Efficacy of atelocollagen honeycomb scaffold in bone formation using KUSA/A1 cells

Andrea Paola Rodriguez, Liliana Missana, Hitoshi Nagatsuka, Mehmet Gunduz, Hidetsugu Tsujigiwa, Rosario Rivera, Noriyuki Nagai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

To induce new bone formation, mesenchymal stem cells were seeded onto atelocollagen honeycomb scaffold. We evaluated the efficacy of this scaffold combined with KUSA/A1 cells in vivo. KUSA/A1 cells alone and with atelocollagen were implanted in the subcutaneous pockets of 4-week-old male SCID mice. The transplants were subjected to radiographical, histological, and immunohistochemical examinations after 2 and 4 weeks of implantation. Radiographically, both KUSA/A1 cells alone and KUSA/A1-atelocollagen showed some radiopaque areas formation but the latter disclosed a larger amount. Histologically, KUSA/A1 cells alone showed few small islands of new bone formation surrounded by a thin layer of cellular proliferation. On the other hand, KUSA/A1-atelocollagen revealed abundant new bone formation as well as cellular proliferation. We also determined the immunolocalization of type I collagen, CD34, osteocalcin, osteopontin, and PCNA in this newly formed bone. Our results indicated that collagen scaffold plays an important role allowing vessel formation and cell anchorage, especially through the proliferation and differentiation process in a confined space. This study supports tissue engineering as an alternative for treating different target diseases, such as trauma or congenital defects, and enhances existing therapeutic applications.

Original languageEnglish
Pages (from-to)707-717
Number of pages11
JournalJournal of Biomedical Materials Research - Part A
Volume77
Issue number4
DOIs
Publication statusPublished - Jun 15 2006

Fingerprint

Scaffolds
Bone
Collagen
Transplants
Osteopontin
Osteocalcin
Proliferating Cell Nuclear Antigen
Scaffolds (biology)
Collagen Type I
Stem cells
Tissue engineering
Defects
atelocollagen

Keywords

  • Atelocollagen
  • Bone formation
  • Honeycomb scaffold
  • Immunohistochemical staining
  • KUSA/A1 cells
  • Tissue engineering

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Efficacy of atelocollagen honeycomb scaffold in bone formation using KUSA/A1 cells. / Rodriguez, Andrea Paola; Missana, Liliana; Nagatsuka, Hitoshi; Gunduz, Mehmet; Tsujigiwa, Hidetsugu; Rivera, Rosario; Nagai, Noriyuki.

In: Journal of Biomedical Materials Research - Part A, Vol. 77, No. 4, 15.06.2006, p. 707-717.

Research output: Contribution to journalArticle

Rodriguez, Andrea Paola ; Missana, Liliana ; Nagatsuka, Hitoshi ; Gunduz, Mehmet ; Tsujigiwa, Hidetsugu ; Rivera, Rosario ; Nagai, Noriyuki. / Efficacy of atelocollagen honeycomb scaffold in bone formation using KUSA/A1 cells. In: Journal of Biomedical Materials Research - Part A. 2006 ; Vol. 77, No. 4. pp. 707-717.
@article{11a84c1822ec45dda6a318b4aa298d8a,
title = "Efficacy of atelocollagen honeycomb scaffold in bone formation using KUSA/A1 cells",
abstract = "To induce new bone formation, mesenchymal stem cells were seeded onto atelocollagen honeycomb scaffold. We evaluated the efficacy of this scaffold combined with KUSA/A1 cells in vivo. KUSA/A1 cells alone and with atelocollagen were implanted in the subcutaneous pockets of 4-week-old male SCID mice. The transplants were subjected to radiographical, histological, and immunohistochemical examinations after 2 and 4 weeks of implantation. Radiographically, both KUSA/A1 cells alone and KUSA/A1-atelocollagen showed some radiopaque areas formation but the latter disclosed a larger amount. Histologically, KUSA/A1 cells alone showed few small islands of new bone formation surrounded by a thin layer of cellular proliferation. On the other hand, KUSA/A1-atelocollagen revealed abundant new bone formation as well as cellular proliferation. We also determined the immunolocalization of type I collagen, CD34, osteocalcin, osteopontin, and PCNA in this newly formed bone. Our results indicated that collagen scaffold plays an important role allowing vessel formation and cell anchorage, especially through the proliferation and differentiation process in a confined space. This study supports tissue engineering as an alternative for treating different target diseases, such as trauma or congenital defects, and enhances existing therapeutic applications.",
keywords = "Atelocollagen, Bone formation, Honeycomb scaffold, Immunohistochemical staining, KUSA/A1 cells, Tissue engineering",
author = "Rodriguez, {Andrea Paola} and Liliana Missana and Hitoshi Nagatsuka and Mehmet Gunduz and Hidetsugu Tsujigiwa and Rosario Rivera and Noriyuki Nagai",
year = "2006",
month = "6",
day = "15",
doi = "10.1002/jbm.a.30645",
language = "English",
volume = "77",
pages = "707--717",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Efficacy of atelocollagen honeycomb scaffold in bone formation using KUSA/A1 cells

AU - Rodriguez, Andrea Paola

AU - Missana, Liliana

AU - Nagatsuka, Hitoshi

AU - Gunduz, Mehmet

AU - Tsujigiwa, Hidetsugu

AU - Rivera, Rosario

AU - Nagai, Noriyuki

PY - 2006/6/15

Y1 - 2006/6/15

N2 - To induce new bone formation, mesenchymal stem cells were seeded onto atelocollagen honeycomb scaffold. We evaluated the efficacy of this scaffold combined with KUSA/A1 cells in vivo. KUSA/A1 cells alone and with atelocollagen were implanted in the subcutaneous pockets of 4-week-old male SCID mice. The transplants were subjected to radiographical, histological, and immunohistochemical examinations after 2 and 4 weeks of implantation. Radiographically, both KUSA/A1 cells alone and KUSA/A1-atelocollagen showed some radiopaque areas formation but the latter disclosed a larger amount. Histologically, KUSA/A1 cells alone showed few small islands of new bone formation surrounded by a thin layer of cellular proliferation. On the other hand, KUSA/A1-atelocollagen revealed abundant new bone formation as well as cellular proliferation. We also determined the immunolocalization of type I collagen, CD34, osteocalcin, osteopontin, and PCNA in this newly formed bone. Our results indicated that collagen scaffold plays an important role allowing vessel formation and cell anchorage, especially through the proliferation and differentiation process in a confined space. This study supports tissue engineering as an alternative for treating different target diseases, such as trauma or congenital defects, and enhances existing therapeutic applications.

AB - To induce new bone formation, mesenchymal stem cells were seeded onto atelocollagen honeycomb scaffold. We evaluated the efficacy of this scaffold combined with KUSA/A1 cells in vivo. KUSA/A1 cells alone and with atelocollagen were implanted in the subcutaneous pockets of 4-week-old male SCID mice. The transplants were subjected to radiographical, histological, and immunohistochemical examinations after 2 and 4 weeks of implantation. Radiographically, both KUSA/A1 cells alone and KUSA/A1-atelocollagen showed some radiopaque areas formation but the latter disclosed a larger amount. Histologically, KUSA/A1 cells alone showed few small islands of new bone formation surrounded by a thin layer of cellular proliferation. On the other hand, KUSA/A1-atelocollagen revealed abundant new bone formation as well as cellular proliferation. We also determined the immunolocalization of type I collagen, CD34, osteocalcin, osteopontin, and PCNA in this newly formed bone. Our results indicated that collagen scaffold plays an important role allowing vessel formation and cell anchorage, especially through the proliferation and differentiation process in a confined space. This study supports tissue engineering as an alternative for treating different target diseases, such as trauma or congenital defects, and enhances existing therapeutic applications.

KW - Atelocollagen

KW - Bone formation

KW - Honeycomb scaffold

KW - Immunohistochemical staining

KW - KUSA/A1 cells

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=34247199841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247199841&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.30645

DO - 10.1002/jbm.a.30645

M3 - Article

C2 - 16555268

AN - SCOPUS:34247199841

VL - 77

SP - 707

EP - 717

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 4

ER -